RBBP5 and cancer: Although the core subunits of KMT2 complexes such as WDR5, RBBP5, DPY30, and ASH2L are rarely deleted or carry genetic mutations, they are frequently amplified or upregulated in human cancers and act as oncogenes [218,228,230,232,284].